|
- 积分
- 3
- 威望
- 3
- 包包
- 15
|
A review of gene and stem cell therapy in cutaneous wound healing ! c9 |3 j% ]7 }! N
A Stem Cell Niche for Intermediate Progenitor Cells of the Embryonic Cortex
* W9 D7 D7 W0 \/ TAcute Complications of Stem Cell Transplant 9 J, j2 o: U8 o/ \
Adhesion within the stem cell niches % I: x5 M' ^0 N) [' ^/ X
Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma
) A7 n& H' t) A" ?5 t, @' W2 zBeliefs About Science and News Frames in Audience Evaluations of Embryonic and Adult Stem Cell Research
2 Y& p# |7 R5 _2 `bone-What is the true nature of the osteoblastic hematopoietic stem cell niche
3 |& L% w' G7 U( t. q% r/ h3 fApoptosis signaling in cancer stem cells
9 y4 L- b* H- n2 t9 KNonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
o& Y: R8 m' y3 R0 [0 qRecurrence cancer stem cells 2 `+ X& B( u# x0 l& ~3 i9 n
Stem cells in melanoma development
( J- z, ^: k. SCompetitive Interactions Between Cells , N* D; U. w- P+ _+ ]
Cord blood stem cells for hematopoietic stem cell transplantation in the UK
/ p4 b$ c% O" ~9 b. _) G: eA chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke
% O) v/ q: B& q' E5 n: jCardiac stem-progenitor cells, secreted proteins, and proteomics 1 N4 w1 D( v: R% d. Z i
Cardiovascular stem cells in regenerative medicine
0 J6 `! \5 ~7 ^3 R% TEndogenous stem cells in patients undergoing coronary artery bypass
; k% q- D/ R }0 M9 r* _Enhancing cardiac stem cell differentiation into cardiomyocytes , [& r5 ?4 J+ a1 B1 m( w# D }( J
In Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods 1 L$ O* k1 V `4 O1 a- o! c
Resident cardiac stem-progenitor cells for cardiac regeneration
' V7 w0 M) X! o! V/ L0 KS1+ Stem Cell Survival and Engraftment in the Infarcted Heart
/ C- X' i" M; E( d9 A; qStem cell engineering for treatment of heart diseases 9 W- ]- |0 t: V' q |
Stem cell therapy in acute myocardial infarction " k! D6 m) `. c4 O% \2 }; ^
Stem Cell Therapy Is Proarrhythmic
; v4 N8 q6 \* ~Stem Cell Therapy-A Primer for Interventionalists and Imagers 1 o# v. t7 d& y/ x' t9 S
diabetes-Mesenchymal stem cells-Stem cell therapy perspectives for type 1 diabetes
& d# c4 e& x$ a1 x3 GEmbryonic stem cells as a model for cardiac development and disease
4 F, ^& A/ K. PEpigenetic dynamics of stem cells and cell lineage commitment " b9 Y/ {$ ]/ I% t
Epileptic Spasms After Stem Cell Transplantation for Chronic Epstein-Barr Virus Infection 5 f$ ]/ W/ i5 x& }. O, J1 H
Expanding Indications for Stem Cell Transplantation
, v. C8 x a9 t2 h. w+ w) H) H1 pFatal nephrotic syndrome complicating allogeneic stem cell transplantation , B3 k3 `0 m2 x- Q" f' D5 \
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
! p* X0 f( j3 I+ k7 dHematopoietic stem cell origin of adipocytes
1 R) H3 A1 | V2 s& t9 ZHepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis
( m( N* I5 {. b% D0 ~3 E# [) ?0 _Long-term microcarrier suspension cultures of human embryonic stem cells ( V7 e+ A5 O- X$ F5 T9 m8 W
Microsphere-based tracing and molecular delivery in embryonic stem cells
8 {8 g$ q8 w0 \Microspheres as a vehicle for biomolecule delivery to neural stem cells
& d' _1 b2 Z8 P# BNew insights into liver stem cells
- ^* d3 _( V7 Q' ]) F9 y/ ~A NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS 2 M, `/ K8 ~: p$ z" ~
Regeneration of the ischemic brain by engineered stem cells 4 e& y0 t+ P3 n
Stem cell-based cell replacement strategies for the central nervous system
2 R4 ]5 P" R5 A4 J* ` B* W7 V: j3 D/ nPercutaneous intramyocardial stem cell injection in patients with acute myocardial infarction
" a n- ?- O5 ]" L( EPeripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction
$ l% y3 A: o& u* ]& v' UPluripotent stem cells as new drugs 4 |/ a4 Y+ \" ?) y
regenerative-The complexity of cellular dedifferentiation-implications for regenerative medicine 0 j+ s9 [0 n$ ]- h z+ p. R8 Q7 ]
respir-Cell therapy approaches for lung diseases " d# S" S) i9 J5 K1 y9 f
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation
" |' H8 m( I. l" Y9 URole of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation ; S! J: ^: L8 L/ s2 n1 W
Role of Hematopoietic Stem Cell Transplant in the Management of Follicular Lymphoma
6 v+ b- [: y* }% y/ _: i3 AStatus of adult marrow stem cell biology
2 o( k b- U9 b; J; sStem cell and genetic therapies for the fetus [/ ~8 e) [1 o, l9 E9 ]
Stem cell decision making and critical-like exploratory networks 2 m: G% b5 g3 y+ o6 a
Stem Cell Therapy for Heart Failure 2 v& [: u) Y% ?* R8 J8 f
Stem Cell Therapy for the Kidney ( }+ J, u3 @% q+ Z) l# i- j
Stem Cells and Liver Regeneration j: B: h8 s! c0 N! t$ Q- U
Stem cells, microenvironment mechanics, and growth factor activation ) u! L" @* o8 I& A' C
Stem cells-The highs and lows of pluripotency / }) L [9 \, O9 @
Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation 6 }" F" r5 M" Y( z0 a' t3 A2 z
Survivorship Issues in Hematopoietic Stem Cell Transplantation ( n w+ Q3 \& x, |
Telomere length maintenance in stem cell populations 4 e' p$ ]4 @6 n1 l2 K. h0 L1 g
Teratoma formation by human embryonic stem cells
1 ?6 M# R8 J2 P3 V0 yThe Development of Inflammatory Arthritis and Other Rheumatic Diseases Following Stem Cell Transplantation
% z, `4 U3 I; cThe Increasing Complexity of the Cancer Stem Cell Paradigm * ~ }9 b5 W+ r1 g' P4 ~# c# c7 ?# J
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis 2 m) W9 J b1 U9 j. g! C6 c( [
Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation 1 ^0 F" {$ B% c1 z3 S- G+ d/ W4 _/ m
Variation in the safety of induced pluripotent stem cell lines
9 p [6 |& I; N* X* t& q3 M) _A niche play for stem cells , z, U5 x2 J1 j; o
A niche play for stem cells - P- ?4 t1 @. S" g( a( u
A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells " ^* Q1 H; j( u% {, K: n5 @
Acute Complications of Stem Cell Transplant 2 |: @$ N( w. [( z, y7 L' N
Adipose-Derived Stem Cells D* t: f: Y6 {* ^# x- k
Adult neural stem cells in the mammalian central nervous system
# [& c0 d$ k$ \, eApoptosis Signaling in Cancer Stem Cells & c& l8 R8 O4 e/ ?6 ^& c$ }
Automated selection and collection of pluripotent stem cell colonies using the CellCelector
9 t: _: z- b0 g1 W; e3 `BCOR regulates mesenchymal stem cell function by epigenetic mechanisms
# N p1 ?+ Z3 u+ `: d& jBmi-1, stem cells and cancer
2 P3 {+ n0 x' x+ E; F' {cancer stem cell marker
8 t# D* ^+ `6 I8 B9 n: y( RCancer stem cells ; b& f. t8 ^( u! M. K" u
Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases 7 h) ~& [' `: n/ e% q
Competitive Interactions Between Cells-Death, Growth, and Geography 9 v+ m- f4 V8 O# T7 n
Potential novel pharmacological therapies for myocardial remodelling 4 D1 Y) q- l: G1 `* R' H8 ~
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
( I4 g- P+ b# |9 t# V3 ~: U) r: y- A1 O& ~6 LElite and stochastic models for induced pluripotent stem cell generation ! z# j1 C# @' G' Y; g7 g
Embryonic stem (ES) cell-derived cardiomyocytes
h L7 x3 V6 _* @3 L9 g. wEmerging Immunology of Stem Cell Transplantation
" `+ K, x0 I7 W: lEthical Issues in Stem Cell Research
1 s+ ~; k; }8 S" V4 [3 xFDA Regulation of Stem Cell Based Products
0 J( ?: A% A1 K7 D& d! s8 uGrowth Factors, Matrices, and Forces Combine and Control Stem Cells
6 D5 W. U) z2 F! ]( rHuman embryonic stem cells and cardiac repair
( G& ~* I, Z3 m, U" g9 ?Human Fetal Membranes-A Source of Stem Cells for Tissue Regeneration and Repair 9 H8 u% r. I0 z3 W
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages
3 o0 K/ ~6 V7 @$ i0 TIFN-wakes up sleeping hematopoietic stem cells
1 _: w% X* _$ ^5 N5 zImaging Stem Cell Implant for Cellular-Based Therapies
~3 _ B7 e7 R/ r1 p4 mImplications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
" Y B5 ], O% N! B3 B/ \* @- vInduced pluripotent stem cells and the stability of the differentiated state # Q* L5 I$ T% S
Instructing an Embryonic Stem Cell-Derived Oocyte Fate
g8 i1 T0 ^" NMedical Innovation Versus Stem Cell Tourism : t! z+ x4 I& h4 ^. W; I* g8 {
In Search of Adrenocortical Stem and Progenitor Cells
) H+ Y, L% h' I% \ ~Neural stem cells aplenty
& o( k# B2 j$ P+ i& Y$ QPancreatic cancer stem cells
# N: K _; P8 `+ q1 TParacrine Mechanisms in Adult Stem Cell Signaling and Therapy 4 v) V! z( k4 \8 P, w9 o! v
Psychological Issues of Stem Cell Transplant
- S8 U0 F7 J9 a* }& i& c0 FRegeneration of the ischemic brain by engineered stem cells
; `0 d3 K, I1 cRegulatory circuits underlying pluripotency and reprogramming 3 h% a$ f+ i1 l$ k& Z! X! m( V
respir-Cell therapy approaches for lung diseases * y- v( I# R: E' t
Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation 5 _- u5 @. F! o7 ]+ R' L5 l
specific microRNAs promote induced pluripotency : f: | n$ X7 }
Stem Cell Therapy for the Kidney : Y" x) S+ y0 \1 I8 N
stem cell therapy in cutaneous wound healing
r# ?! o) H# c) pStem cell therapy perspectives for type 1 diabetes ) T$ ^* p8 M# X3 i U% P
Stem Cells and Liver Regeneration 4 Q9 j" _) r7 g9 J: ~
Stem cells based transplantation for cardiovascular diseases in China
1 C7 @& d6 V) ~4 A4 W* z2 ~! QStem-cell therapy faces more scrutiny in China
2 t+ B, x' T4 Y- s4 k# E8 D. fSteps to the Clinic
* ]1 r/ k8 ?' I8 CStepwise differentiation of pluripotent stem cells into retinal cells - s+ W$ q( G/ m8 z0 {3 M; _& b w
Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche : n1 `. L( E' j0 \" `- E% Y0 {
The Increasing Complexity of the Cancer Stem Cell Paradigm
# _9 y3 U$ E1 w& v' Z/ iThe NIH Draft Guidelines on Human Stem Cell Research
" `: Q* r, v3 d) m1 x& H9 Y! ?+ MThe pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting
2 T1 T8 D3 n) m3 ~6 _) ?8 f2 dThe Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair * G: P2 y- P0 e$ ?" A2 P
The tumor stem cell concept
8 K. M2 D0 m" e kUmbilical cord blood stem cells-Towards a proteomic approach : S( ?) E& V# I
US regulator wades into stem cell therapies for heart disease
, o% m' }) Q& G$ F H& `5 z( hApoptosis Signaling in Cancer Stem Cells . [4 I1 x3 Z/ x* @/ y6 Y) E+ T# c
Pancreatic cancer stem cells
* x" ~9 r% O# R& hAcute Complications of Stem Cell Transplant
4 C. O0 t2 c- ?! G3 EAutologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma
0 l' q! U% t: K. M* mDeconstructing Stem Cell Tumorigenicity-A Roadmap to Safe Regenerative Medicine 0 |9 M$ L8 z! v4 n9 p. u3 X
Emerging Immunology of Stem Cell Transplantation ( k7 p. w9 y, Q/ s: _- i% D8 T
Management Issues In Hematopoietic Stem Cell Transplantation 8 p$ I/ P( r- M. c5 ~( o& L$ t: S
Psychological Issues of Stem Cell Transplant
) A, @% H! o1 {- K& J% n$ ], fThe NIH Draft Guidelines on Human Stem Cell Research 8 s, B1 q' A! k8 E- R! P1 `9 ]
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
* w" ~# S" ?) m" u0 x s: YBone Marrow-derived Stem-Progenitor Cells-Their Use in Clinical Studies for the Treatment of Myocardial Infarction / h5 ?& M/ }; K6 p
Embryonic stem (ES) cell-derived cardiomyocytes
, t$ e% L) s3 s/ `9 V0 vEmbryonic stem cells as a model for cardiac development and disease
8 e' `7 g) @( h/ XEndogenous stem cells in patients undergoing coronary artery bypass graft surgery
& {/ q6 c+ a6 T9 RHuman embryonic stem cells and cardiac repair
1 |% Y9 j! \1 ^: k% p; U- k v3 ~4 wPercutaneous intramyocardial stem cell injection in patients with acute myocardial infarction 1 b, d4 l+ I! U8 r1 b
Promise of Blood-and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair
( Q% U% k- \2 B9 ]7 {% w* aStem Cell Therapy for Heart Failure ( p- ^- E- z- R, ?( ?7 i
Epithelial metaplasia-adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation
" B; i- q& U) MFull text access provided to Peking university
8 Z; p$ W& e2 M: N5 J: F6 j) iImproving stem cell mobilization strategies-future directions
+ P5 Z4 r- m( p- A! nInduced pluripotent stem cells from a spinal muscular atrophy patient
4 e. H/ |0 T5 F% MInduced pluripotent stem cells-current progress and potential for regenerative medicine
5 O C) ~3 b) K/ ^Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon鈥揹ependent exhaustion 2 S, Y- O4 b% u. E7 h- J# d) X
Low-risk reprogramming
9 u/ i4 t6 p% o5 SMolecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells 0 i2 g: h% \2 j4 ?2 {3 {. k0 a
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells 9 u' m m- r s
Pluripotent stem cells as new drugs 1 X0 O! s+ n# n' [
proteome-Umbilical cord blood stem cells-Towards a proteomic approach . {; G3 r3 ~5 L
Regeneration of the ischemic brain by engineered stem cells
/ [2 x# X/ U/ T; @4 _% `Researchers Generally Happy With Final Stem Cell Rules
. Q- A9 v2 D+ \/ l# FStem Cell Niche
1 T5 z8 h4 ?0 ^6 f, F: oStem cell therapy perspectives for type 1 diabetes
, C8 S( S, u4 v8 n- T3 @6 {% O6 q5 OStem Cells and Liver Regeneration
" f. ^ v; }0 l) \Stem cells-Fast and furious
' X L! |4 z1 O+ H+ b9 ~Survivorship Issues in Hematopoietic Stem Cell Transplantation {. o4 s% c: \1 _# h
The NIH Draft Guidelines on Human Stem Cell Research & [) H% i! n- Q3 s c
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
% n( O" b: A1 P0 LUS stem-cell research expands
' B4 l5 _" [3 q* GVirus-free induction of pluripotency and subsequent excision of reprogramming factors
/ }) w" L6 m; D' QWnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin |
|
发表于 2009-10-29 19:08
